This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Blanchard, D. K., Friedman, H., Stewart, II, W. E., Klein, T. W., and Djeu, J. Y. (1988). Role of γ-interferon in induction of natural killer activity by Legionella pneumophila in vitro and in an experimental murine infection model. Infect. Immun. 56:1187–1193.
Friedman, H., Widen, R., Klein, T., and Johnson, W. (1984). Immunostimulation by Legionella pneumophila antigen preparations in vivo and in vitro. Infect. Immun. 43:347–352.
Yamamoto, Y., Klein, T. W., Newton, C. A., and Friedman, H. (1992). Differing macrophage and lymphocyte roles in resistance to Legionella pneumophila infection. J. Immunol. 148:584–589.
Blanchard, D. K., Newton, C., Klein, T. W., Stewart II, W. E., and Friedman, H. (1986). In vitro and in vivo suppressive effects of Δ9-tetrahydrocannabinol on interferon production by murine spleen cells. Intl. J. Immunopharmacol. 8:819–824.
Klein, T. W., Newton, C., Larsen, K., Chou, J., Perkins, I., Lu, L. et al. (1993). Cannabinoid receptors and T helper cells. J. Neuroimmunol. 147:91–94. 2004.
Newton, C. A., Klein, T. W., and Friedman, H. (1994). Secondary immunity to Legionella pneumophila and Th1 activity are suppressed by delta-9-tetrahydrocannabinol injection. Infect. Immun. 62:4015–4020.
Klein, T. W., Lane, B., Newton, C. A., and Friedman, H. (2000). The cannabinoid system and cytokine network. Proc. Soc. Exp. Biol. Med. 225:1–8.
Bradley, S. G., Munston, A. E., Dewey, W. L., and Harris, L. S. (1977). Enhanced susceptibility of mice to combinations of Δ9-tetrahydrocannabinol and live or killed gram-negative bacteria. Infect. Immun. 17:325–329.
Cabral, G. A., Lockmuller, J. C., and Mishkin, E. M. (1986). Δ9-Tetrahydrocannabinol decreases α/β-interferon response to herpes simplex virus type 2 in the B6C3F1 mouse. Proc. Soc. Exp. Biol. Med. 181:305–311.
Cabral, G. A., Mishkin, E. M., Marciano-Cabral, F., Coleman, P., Harris, L., and Munson, A. E. (1986). Effect of Δ9-tetrahydrocannabinol on herpes simplex virus type 2 vaginal infection in the guinea pig. Proc. Soc. Exp. Biol. Med. 182:181–186.
Cabral, G. and Dove Pettit, D. (1998). Drugs and immunity: Cannabinoids and their role in decreased resistance to infectious diseases. J. Neuroimmunol. 83:116–123.
Juel-Jensen, B. E. (1972). Cannabis and recurrent herpes simplex. Br. Med. J. 4:296.
Morahan, P. S., Klykken, P. C., Smith, S. H., Harris, L. S., and Munson, A. E. (1979). Effects of cannabinoids on host resistance to Listeria monocytogenes and herpes simplex virus. Infect. Immun. 23:670–674.
Specter, S., Lancz, G., Westrich, G., and Friedman, H. (1991). Delta-9-tetrahydrocannabinol augments murine retroviral induced immunosuppression and infection. Int. J. Immunopharmacol. 13:411–417.
Friedman, H., Klein, T., and Specter, S. (1991). Immunosuppression by marijuana and components. In R. Ader, D. L. Felten, and H. Cohen (eds), Psychoneuroimmunology, 2nd edn. Academic Press, New York, pp. 931–953.
Friedman, H., Shivers, S., and Klein, T. W. (1994). Drugs of abuse and the immune system. In J. Dean, M. Luster, A. Munson, and I. Kimber (eds), Immunotoxicology Immunopharmacology, 2nd edn. Raven Press, New York, pp. 303–322.
Klein, T. W., Newton, C., Widen, R., and Friedman, H. (1993). Δ9-tetrahydrocannabinol injection induces cytokine-mediated mortality of mice infected with Legionella pneumophila. J. Pharmacol. Exp. Ther. 267:635–640.
Klein, T. W., Newton, C., and Friedman, H. (1994). Resistance to Legionella pneumophila suppressed by the marijuana component, tetrahydrocannabinol. J. Infect. Dis. 169:1177–1179.
Klein, T. W., Newton, C. A. and Friedman, H. (2001). Cannabinoid and the immune system. Pain Res. Manage. 6:95–101.
Huber, G. L., Simmons, G. A., McCarthy, C. R., Cutting, M. B., Laguarda, R., and Pereira, W. (1975). Depressant effect of marijuana smoke on antibacterial activity of pulmonary alveolar macrophages. Chest 68:769–773.
Mann, P. E. G., Cohen, A. B., Finley, T. N., and Ladman, A. L. (1971). Alveolar macrophages: Structural and functional differences between nonsmokers and smokers of marijuana and tobacco. Lab. Invest. 25:111–120.
Klein, T., Friedman, H., and Specter, S. (1998). Marijuana immunity and infection. J. Neuroimmunol. 83:102–115.
Lopez-Cepero, M., Friedman, M., Klein, T., and Friedman, H. (1986). Tetrahydrocannabinol-induced suppression of macrophage spreading and phagocytic activity in vitro. J. Leukoc. Biol. 39:679–686.
Rachelefsky, G. S., Opelz, G., Mickey, M. R., Lessin, P., Kiuch, M., Silverstein, M. J. et al. (1976). Humoral and cell-mediated immunity in chronic marijuana smoking. J. Allergy Clin. Immunol. 58:483–490.
Raz, A. and Goldman, R. (1976). Effect of hashish compounds on mouse peritoneal macrophages. Lab. Invest. 34:69–76.
Zimmerman, S., Zimmerman, A., M., Cameron, I. L., and Laurence, H. L. (1977). Δ1-Tetrahydrocannabinol, cannabidiol, and cannabinol effects on immune response of mice. Pharmacology. 15:10–23.
Specter, S., Lancz, G., and Friedman, H. (1990). Marijuana and immunosuppression in man. In R.R. Watson (ed.), Drugs of Abuse and Immune Function, CRC Press, Boca Raton, FL, pp. 73–85.
Pross, S., Klein, T., Newton, C., and Friedman, H. (1987). Differential effects of marijuana components on proliferation of spleen, lymph node and thymus cells. Int. J. Immunopharmacol. 9:363–370.
Klein, T., Newton, C., and Friedman, H. (1998). Cannabinoid receptors and immunity. Immunol. Today 19:373–381.
Klein, T. W., Newton, C. A., Nakachi, H., and Friedman, H. (2000). Δ9-Tetrahydrocannabinol treatment suppresses immunity and early IFN-γ, IL-12, and IL-12 receptor β2 responses to Legionella pneumophila infection. J. Immunol. 164:6461–6466.
Yuan, M., Kiertscher, S. M., Cheng, Q., Zoumalan, R., Tashkin, D. P., and Roth, M. D. (2002). Δ9-Tetrahydrocannabinol regulates Th1/Th2 cytokine balance in activated human T cells. J. Neuroimmunol. 133:124–131.
Zhu, L. X., Sharma, S., Stolina, M., Gardner, B., Roth, M. D., Tashkin, D. P. et al. (2000). Δ9-Tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165:373–380.
Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61–65.
Shire, D., Calandra, B., Rinaldi-Carmona, M., Oustric, D., Pesegue, B., Bonnin-Cabanne, O. et al. (1996). Molecular cloning, expression, and function of the murine CB2 peripheral cannabinoid receptor. Biochim. Biophys. Acta 1307:132–136.
Moser, M. and Murphy, K. (2000). Dendritic cell regulation of Th1-Th2 development. Nat. Immunol. 1:199–205.
Ouyang, W., Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L., Sha, W. C. et al. (1998). Inhibition of Th1 development mediated by GATA 3 through an IL-4-independent mechanism. Immunity 9:745–755.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Friedman, H., Newton, C., Klein, T.W. (2005). Legionella Infection and Cannabinoids. In: Friedman, H., Klein, T.W., Bendinelli, M. (eds) Infectious Diseases and Substance Abuse. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-48688-1_5
Download citation
DOI: https://doi.org/10.1007/0-306-48688-1_5
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48687-6
Online ISBN: 978-0-306-48688-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)